Doug Schenkel
Stock Analyst at Wolfe Research
(3.62)
# 801
Out of 5,057 analysts
68
Total ratings
54%
Success rate
35.05%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Upgrades: Outperform | $75 | $94.13 | -20.32% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $24.30 | +31.69% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $67.94 | -11.69% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $74.26 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $29.90 | +100.67% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $22.65 | +23.65% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $266.66 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $150.56 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $3.25 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $221.20 | +28.84% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $41.79 | - | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $146.89 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $44.65 | +15.34% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $16.35 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $119.93 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $67.75 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $580.13 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.35 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $93.40 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.63 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $11.70 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $200.67 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $379.30 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.38 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.64 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.95 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.81 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.04 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $11.32 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.63 | +1,004.29% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $17.53 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $332.67 | -72.95% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.32 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $198.81 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $59.72 | -73.21% | 2 | Sep 28, 2017 |
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $94.13
Upside: -20.32%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $24.30
Upside: +31.69%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $67.94
Upside: -11.69%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $74.26
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $29.90
Upside: +100.67%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $22.65
Upside: +23.65%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $266.66
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $150.56
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.25
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $221.20
Upside: +28.84%
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $41.79
Upside: -
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $146.89
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $44.65
Upside: +15.34%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $16.35
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $119.93
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $67.75
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $580.13
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $6.35
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $93.40
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.63
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $11.70
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $200.67
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $379.30
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.38
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.64
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.95
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.81
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.04
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $11.32
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.63
Upside: +1,004.29%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $17.53
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $332.67
Upside: -72.95%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.32
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $198.81
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $59.72
Upside: -73.21%